Cemented, cementless, and hybrid prostheses for total hip replacement: cost effectiveness analysis

Objective To compare the cost effectiveness of the three most commonly chosen types of prosthesis for total hip replacement. Design Lifetime cost effectiveness model with parameters estimated from individual patient data obtained from three large national databases. Setting English National Health Service. Participants Adults aged 55 to 84 undergoing primary total hip replacement for osteoarthritis. Interventions Total hip replacement using either cemented, cementless, or hybrid prostheses. Main outcome measures Cost (£), quality of life (EQ-5D-3L, where 0 represents death and 1 perfect health), quality adjusted life years (QALYs), incremental cost effectiveness ratios, and the probability that each prosthesis type is the most cost effective at alternative thresholds of willingness to pay for a QALY gain. Results Lifetime costs were generally lowest with cemented prostheses, and postoperative quality of life and lifetime QALYs were highest with hybrid prostheses. For example, in women aged 70 mean costs were £6900 ($11 000; €8200) for cemented prostheses, £7800 for cementless prostheses, and £7500 for hybrid prostheses; mean postoperative EQ-5D scores were 0.78, 0.80, and 0.81, and the corresponding lifetime QALYs were 9.0, 9.2, and 9.3 years. The incremental cost per QALY for hybrid compared with cemented prostheses was £2500. If the threshold willingness to pay for a QALY gain exceeded £10 000, the probability that hybrid prostheses were most cost effective was about 70%. Hybrid prostheses have the highest probability of being the most cost effective in all subgroups, except in women aged 80, where cemented prostheses were most cost effective. Conclusions Cemented prostheses were the least costly type for total hip replacement, but for most patient groups hybrid prostheses were the most cost effective. Cementless prostheses did not provide sufficient improvement in health outcomes to justify their additional costs.

[1]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[2]  Communities,et al.  English Indices of Deprivation , 2013 .

[3]  Andrew Briggs,et al.  The “Hazards” of Extrapolating Survival Curves , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  J. Sekhon,et al.  Genetic Matching for Estimating Causal Effects: A General Multivariate Matching Method for Achieving Balance in Observational Studies , 2006, Review of Economics and Statistics.

[5]  Roland R. Ramsahai,et al.  Evaluating treatment effectiveness in patient subgroups: a comparison of propensity score methods with an automated matching approach , 2012, The international journal of biostatistics.

[6]  P. Pynsent,et al.  Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study , 2012, BMJ : British Medical Journal.

[7]  J. Sekhon,et al.  Methods for Estimating Subgroup Effects in Cost-Effectiveness Analyses That Use Observational Data , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

[8]  J. Sekhon,et al.  A matching method for improving covariate balance in cost-effectiveness analyses. , 2012, Health economics.

[9]  P. Dieppe,et al.  Failure rates of stemmed metal-on-metal hip replacements: analysis of data from the National Joint Registry of England and Wales , 2012, The Lancet.

[10]  Andrew Briggs,et al.  An Introduction to Markov Modelling for Economic Evaluation , 1998, PharmacoEconomics.

[11]  R. Grilli,et al.  Modeling the cost-effectiveness for cement-less and hybrid prosthesis in total hip replacement in Emilia Romagna, Italy. , 2011, The Journal of surgical research.

[12]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[13]  K. Ousey,et al.  Understanding patient reported outcome measures (PROMs). , 2011, British journal of community nursing.

[14]  L. Havelin,et al.  Improved results of primary total hip replacement , 2010, Acta orthopaedica.

[15]  Elhadi Sariali,et al.  Total hip arthroplasty revision due to infection: a cost analysis approach. , 2010, Orthopaedics & traumatology, surgery & research : OTSR.

[16]  L. Havelin,et al.  Improved results of primary total hip replacement Results from the Norwegian Arthroplasty Register , 1987 – 2007 , 2010 .

[17]  Richard Grieve,et al.  Evaluating health care programs by combining cost with quality of life measures: a case study comparing capitation and fee for service. , 2008, Health services research.

[18]  Jasjeet S. Sekhon,et al.  Multivariate and Propensity Score Matching Software with Automated Balance Optimization: The Matching Package for R , 2008 .

[19]  R. Field,et al.  Comparing total hip and knee replacement costs , 2008 .

[20]  M. Marinelli,et al.  Cost-effectiveness of cemented versus cementless total hip arthroplasty. A Markov decision analysis based on implant cost , 2008, Journal of Orthopaedics and Traumatology.

[21]  B. F. Morrey,et al.  Comparison of cemented and uncemented fixation in total hip replacement: A meta-analysis , 2008 .

[22]  A. Toni,et al.  First hip arthroplasty register in Italy: 55,000 cases and 7 year follow-up , 2009, International Orthopaedics.

[23]  I. Brenkel,et al.  Quality of life and functional outcome after primary total hip replacement. A five-year follow-up. , 2007, The Journal of bone and joint surgery. British volume.

[24]  J. Katz,et al.  Survival following total hip replacement. , 2005, The Journal of bone and joint surgery. American volume.

[25]  C. Dibben,et al.  The English indices of deprivation 2004 , 2011 .

[26]  Andrew Briggs,et al.  The use of probabilistic decision models in technology assessment , 2004, Applied health economics and health policy.

[27]  M. Johannesson,et al.  Health-related quality of life by disease and socio-economic group in the general population in Sweden. , 2001, Health policy.

[28]  S. Vollset,et al.  Mortality after total hip replacement: 0-10-year follow-up of 39,543 patients in the Norwegian Arthroplasty Register , 2000, Acta orthopaedica Scandinavica.

[29]  U. Givon,et al.  Cost-Utility Analysis of Total Hip Arthroplasties: Technology Assessment of Surgical Procedures by Mailed Questionnaires , 1998, International Journal of Technology Assessment in Health Care.

[30]  A. Freiberg,et al.  An international comparative study of total hip arthroplasty cost and practice patterns. , 1998, The Journal of arthroplasty.

[31]  T Hansson,et al.  Life Expectancy and Cost Utility After Total Hip Replacement , 1998, Clinical orthopaedics and related research.

[32]  A. Carr,et al.  Questionnaire on the perceptions of patients about total hip replacement. , 1996, The Journal of bone and joint surgery. British volume.

[33]  S. Holmberg Life expectancy after total hip arthroplasty. , 1992, The Journal of arthroplasty.

[34]  A. Williams EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[35]  A. Kasuya EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[36]  R. Hale,et al.  A FIVE-YEAR FOLLOW-UP , 1982 .

[37]  T. Boardman,et al.  Estimation in the piece-wise constant hazard rate model , 1976 .